View in EDS PDF Full Text

Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia.

Saved in:
Bibliographic Details
Title: Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia.
Authors: Ramos-Muntada M; Cell Biology, Physiology and Immunology Department, Genetics of Male Fertility Group, Universitat Autònoma de Barcelona, Spain., Trincado JL; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain., Blanco J; Cell Biology, Physiology and Immunology Department, Genetics of Male Fertility Group, Universitat Autònoma de Barcelona, Spain., Bueno C; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain., Rodríguez-Cortez VC; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain., Bataller A; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.; Hematology Department, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Spain., López-Millán B; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain., Schwab C; Wolfson Childhood Cancer Research Centre, Newcastle University, UK., Ortega M; Hematology Service, Experimental Hematology, Vall d'Hebrón Institute of Oncology (VHIO), Vall d'Hebrón Hospital Universitari, Barcelona, Spain., Velasco P; Pediatric Oncology and Hematology Department, Vall d'Hebrón Hospital, Barcelona, Spain., Blanco ML; Hematology Laboratory, Hospital Sant Pau, Barcelona, Spain., Nomdedeu J; Hematology Laboratory, Hospital Sant Pau, Barcelona, Spain., Ramírez-Orellana M; Hematology Diagnostic Laboratory, Hospital Niño Jesús, Madrid, Spain., Minguela A; Immunology Service, Clinic University Hospital Virgen de la Arrixaca and Instituto Murciano de Investigación Biomédica (IMIB), Murcia, Spain., Fuster JL; Pediatric Hematology and Oncology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain., Cuatrecasas E; Hematology Laboratory, Institut de Recerca Hospital Sant Joan de Déu, Barcelona, Spain., Camós M; Hematology Laboratory, Hospital Sant Joan de Déu, University of Barcelona, Spain.; Leukemia and Other Pediatric Hemopathies, Developmental Tumor Biology Group, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Ballerini P; AP-HP, Service d'Hématologie Pédiatrique, Hôpital A. Trousseau, Paris, France., Escherich G; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Germany., Boer J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., DenBoer M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands., Hernández-Rivas JM; Departamento de Hematología, Salamanca-IBSAL, Hospital Universitario de Salamanca, Spain., Calasanz MJ; CIMA Lab Diagnostics, Universidad de Navarra, Pamplona, Spain., Cazzaniga G; Fondazione Tettamanti, Monza, Italy., Harrison CJ; Wolfson Childhood Cancer Research Centre, Newcastle University, UK., Menéndez P; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Molina O; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.
Source: Molecular oncology [Mol Oncol] 2022 Aug; Vol. 16 (16), pp. 2899-2919. Date of Electronic Publication: 2022 Jul 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35726693
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ramos-Muntada+M%22">Ramos-Muntada M</searchLink>; Cell Biology, Physiology and Immunology Department, Genetics of Male Fertility Group, Universitat Autònoma de Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Trincado+JL%22">Trincado JL</searchLink>; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Blanco+J%22">Blanco J</searchLink>; Cell Biology, Physiology and Immunology Department, Genetics of Male Fertility Group, Universitat Autònoma de Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bueno+C%22">Bueno C</searchLink>; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Cortez+VC%22">Rodríguez-Cortez VC</searchLink>; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bataller+A%22">Bataller A</searchLink>; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.; Hematology Department, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22López-Millán+B%22">López-Millán B</searchLink>; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Schwab+C%22">Schwab C</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University, UK.<br /><searchLink fieldCode="AU" term="%22Ortega+M%22">Ortega M</searchLink>; Hematology Service, Experimental Hematology, Vall d'Hebrón Institute of Oncology (VHIO), Vall d'Hebrón Hospital Universitari, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Velasco+P%22">Velasco P</searchLink>; Pediatric Oncology and Hematology Department, Vall d'Hebrón Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Blanco+ML%22">Blanco ML</searchLink>; Hematology Laboratory, Hospital Sant Pau, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Nomdedeu+J%22">Nomdedeu J</searchLink>; Hematology Laboratory, Hospital Sant Pau, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ramírez-Orellana+M%22">Ramírez-Orellana M</searchLink>; Hematology Diagnostic Laboratory, Hospital Niño Jesús, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Minguela+A%22">Minguela A</searchLink>; Immunology Service, Clinic University Hospital Virgen de la Arrixaca and Instituto Murciano de Investigación Biomédica (IMIB), Murcia, Spain.<br /><searchLink fieldCode="AU" term="%22Fuster+JL%22">Fuster JL</searchLink>; Pediatric Hematology and Oncology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.<br /><searchLink fieldCode="AU" term="%22Cuatrecasas+E%22">Cuatrecasas E</searchLink>; Hematology Laboratory, Institut de Recerca Hospital Sant Joan de Déu, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Camós+M%22">Camós M</searchLink>; Hematology Laboratory, Hospital Sant Joan de Déu, University of Barcelona, Spain.; Leukemia and Other Pediatric Hemopathies, Developmental Tumor Biology Group, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ballerini+P%22">Ballerini P</searchLink>; AP-HP, Service d'Hématologie Pédiatrique, Hôpital A. Trousseau, Paris, France.<br /><searchLink fieldCode="AU" term="%22Escherich+G%22">Escherich G</searchLink>; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Boer+J%22">Boer J</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22DenBoer+M%22">DenBoer M</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hernández-Rivas+JM%22">Hernández-Rivas JM</searchLink>; Departamento de Hematología, Salamanca-IBSAL, Hospital Universitario de Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Calasanz+MJ%22">Calasanz MJ</searchLink>; CIMA Lab Diagnostics, Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Cazzaniga+G%22">Cazzaniga G</searchLink>; Fondazione Tettamanti, Monza, Italy.<br /><searchLink fieldCode="AU" term="%22Harrison+CJ%22">Harrison CJ</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University, UK.<br /><searchLink fieldCode="AU" term="%22Menéndez+P%22">Menéndez P</searchLink>; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Molina+O%22">Molina O</searchLink>; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), ISCIII, Barcelona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2022 Aug; Vol. 16 (16), pp. 2899-2919. <i>Date of Electronic Publication: </i>2022 Jul 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35726693
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/1878-0261.13276
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2899
    Titles:
      – TitleFull: Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ramos-Muntada M
      – PersonEntity:
          Name:
            NameFull: Trincado JL
      – PersonEntity:
          Name:
            NameFull: Blanco J
      – PersonEntity:
          Name:
            NameFull: Bueno C
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Cortez VC
      – PersonEntity:
          Name:
            NameFull: Bataller A
      – PersonEntity:
          Name:
            NameFull: López-Millán B
      – PersonEntity:
          Name:
            NameFull: Schwab C
      – PersonEntity:
          Name:
            NameFull: Ortega M
      – PersonEntity:
          Name:
            NameFull: Velasco P
      – PersonEntity:
          Name:
            NameFull: Blanco ML
      – PersonEntity:
          Name:
            NameFull: Nomdedeu J
      – PersonEntity:
          Name:
            NameFull: Ramírez-Orellana M
      – PersonEntity:
          Name:
            NameFull: Minguela A
      – PersonEntity:
          Name:
            NameFull: Fuster JL
      – PersonEntity:
          Name:
            NameFull: Cuatrecasas E
      – PersonEntity:
          Name:
            NameFull: Camós M
      – PersonEntity:
          Name:
            NameFull: Ballerini P
      – PersonEntity:
          Name:
            NameFull: Escherich G
      – PersonEntity:
          Name:
            NameFull: Boer J
      – PersonEntity:
          Name:
            NameFull: DenBoer M
      – PersonEntity:
          Name:
            NameFull: Hernández-Rivas JM
      – PersonEntity:
          Name:
            NameFull: Calasanz MJ
      – PersonEntity:
          Name:
            NameFull: Cazzaniga G
      – PersonEntity:
          Name:
            NameFull: Harrison CJ
      – PersonEntity:
          Name:
            NameFull: Menéndez P
      – PersonEntity:
          Name:
            NameFull: Molina O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1878-0261
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: Molecular oncology
              Type: main
ResultId 1